{"entity":{"id":"nct00129142","kind":"trial","name":"Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy","aka":[],"tldr":"A phase 3 trial of Toremifene in Prostate cancer, run by GTx, completed.","summary":"Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy is a phase 3 interventional study registered as NCT00129142 by GTx, with 1200 participants recorded, started 2003-10 and reaching its primary completion in 2007-11. Interventions recorded: Toremifene Citrate. Conditions recorded: Prostate Cancer, Osteoporosis, Fractures.\n\nLinked to the drug Toremifene because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.","status":"completed","asOf":"2026-09-22","links":[{"label":"ClinicalTrials.gov NCT00129142","url":"https://clinicaltrials.gov/study/NCT00129142"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["prostate"],"sections":[],"technologies":[],"targets":[],"drugs":["toremifene"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT00129142","phase":"3","setting":"A Randomized, Double Blind, Placebo Controlled, Multicenter Efficacy and Safety Study of Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation Therapy","sponsor":"GTx","enrolled":1200,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct00129142/","neighbours":{"cancer":[{"id":"prostate","kind":"cancer","name":"Prostate cancer","route":"/cancers/prostate/"}],"drug":[{"id":"toremifene","kind":"drug","name":"Toremifene","route":"/drugs/toremifene/"}]}}